Friday, August 22, 2014 Last update: 8:03 PM
FreshNews.com - All Company Technology News Since 1996

Peregrine Pharmaceuticals

News articles for Peregrine Pharmaceuticals:

Monday, August 11, 2014

Monday, July 14, 2014

Monday, July 7, 2014

Tuesday, June 10, 2014

Wednesday, April 23, 2014

Wednesday, April 9, 2014

Monday, April 7, 2014

Tuesday, April 1, 2014

Friday, March 14, 2014

Thursday, March 13, 2014

Tuesday, March 11, 2014

Friday, March 7, 2014

Tuesday, March 4, 2014

Thursday, February 27, 2014

Wednesday, February 19, 2014

  • Peregrine Pharmaceuticals Announces Upcoming Events
    TUSTIN, CA -- (Marketwired) -- 02/19/14 -- Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM), a biopharmaceutical company developing first-in-class monoclonal antibodies focused on the treatment and diagnosis of cancer, today announced that the company will participate in the following investor conferences: 2014 RBC Capital Markets' Global Healthcare Conference Date: Tuesday, February 25, 2014 ... read more
  • Peregrine Pharmaceuticals Announces Closing of Preferred Stock Offering
    TUSTIN, CA -- (Marketwired) -- 02/19/14 -- Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM) (the "Company"), announced today that it has closed its previously announced underwritten public offering of 700,000 shares of its 10.50% Series E Convertible Preferred Stock (the "Series E Preferred Stock") at a public offering price of $25.00 ... read more

Tuesday, February 11, 2014

Wednesday, February 5, 2014

Monday, January 6, 2014